Page 106 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 106
SATURDAY, APRIL 25, 2015
Basic Symposium - Metabolic Disorders: Hall C (Plenary)
Metabolism and cancer: the circadian clock connection
Chair:
Selma Masri, The United States
SCIENTIFIC PROGRAMME 14:00 - 14:30 Partitioning of circadian metabolism in the liver
14:30 - 15:00 Selma Masri, The United States
15:00 - 15:30
Role of SIRT1 in liver regeneration
Marina Bellet, Italy
High-throughput analysis of circadian liver gene expression
Frederic Gachon, Switzerland
Clinical Symposium - Treatment decisions in intermediate stage HCC Strauss 1
Chair:
Jens Ricke, Germany
14:00 - 14:05 A critical appraisal of where we are in the intermediate stage
14:05 - 14:30 today
14:30 - 15:00 Jens Ricke, Germany
15:00 - 15:30 How to determine the appropriate TACE candidate and when
to time the next intervention
Wolfgang Sieghart, Austria
Is there a role of combination treatments today – arguments
and evidence for the combined or sequential use of the current
toolbox
Maciej Pech, Germany
Where is the place for Y90-radioembolization today?
Bruno Sangro, Spain
106 The International Liver Congress™ 2015 • ILC Programme
Basic Symposium - Metabolic Disorders: Hall C (Plenary)
Metabolism and cancer: the circadian clock connection
Chair:
Selma Masri, The United States
SCIENTIFIC PROGRAMME 14:00 - 14:30 Partitioning of circadian metabolism in the liver
14:30 - 15:00 Selma Masri, The United States
15:00 - 15:30
Role of SIRT1 in liver regeneration
Marina Bellet, Italy
High-throughput analysis of circadian liver gene expression
Frederic Gachon, Switzerland
Clinical Symposium - Treatment decisions in intermediate stage HCC Strauss 1
Chair:
Jens Ricke, Germany
14:00 - 14:05 A critical appraisal of where we are in the intermediate stage
14:05 - 14:30 today
14:30 - 15:00 Jens Ricke, Germany
15:00 - 15:30 How to determine the appropriate TACE candidate and when
to time the next intervention
Wolfgang Sieghart, Austria
Is there a role of combination treatments today – arguments
and evidence for the combined or sequential use of the current
toolbox
Maciej Pech, Germany
Where is the place for Y90-radioembolization today?
Bruno Sangro, Spain
106 The International Liver Congress™ 2015 • ILC Programme